| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 02/24/2004 | US6696557 Isolated nucleic acid comprising nucleotide sequence encoding extracellular domain of al-2 fused to immunoglobulin amino acid sequence |
| 02/24/2004 | US6696556 Genetic engineering |
| 02/24/2004 | US6696454 Inhibitors of spermidine synthase for the treatment of osteoarthritis and cartilage rehabilitation |
| 02/24/2004 | US6696303 Inhibition of amyloid protein bnding to neuronal receptor; obtain cell, incubate with modulator, monitor amyloid protein activity |
| 02/24/2004 | US6696286 Method and devices for detecting and enumerating microorganisms |
| 02/24/2004 | US6696285 Double-stranded oligomer with single-stranded extension; faster, controlled addition and removal |
| 02/24/2004 | US6696280 Polypeptide for use in the diagnosis, prevention and treatment of fungal infections |
| 02/24/2004 | US6696277 Based on differential gene expression |
| 02/24/2004 | US6696275 Generating preferential polypeptide; obtain nucleotide sequences, mutate, express nucleotide sequences, separate and recover polypeptide |
| 02/24/2004 | US6696269 Plurality of light emitting diodes; optical monitoring device for illuminating nutrient medium and drug diffusion disks |
| 02/24/2004 | US6696268 Production and use of antimicrobial agents |
| 02/24/2004 | US6696267 Screening compounds that modulate calcium release activated channel activity by contacting compound and calcium channel activator with calcium channel expressing cells containing reporter construct, measuring reporter gene expression |
| 02/24/2004 | US6696266 Diagnosing and monitoring liver injury or failure; sensitive, accurate, inexpensive measurement in blood |
| 02/24/2004 | US6696263 PCNA associated cell cycle proteins, compositions and methods of use |
| 02/24/2004 | US6696256 Rapidly and accurately determining relative expression of different genes in different cells, tissues and organisms over time |
| 02/24/2004 | US6696255 Nucleic acid hairpin probes and uses thereof |
| 02/24/2004 | US6696254 Detection and identification of enteric bacteria |
| 02/24/2004 | US6696253 Method for determining the MHC genotype of chickens |
| 02/24/2004 | US6696252 High-affinity oligonucleotide ligands to vascular endothelial growth factor (VEGF) |
| 02/24/2004 | US6696251 Selection of sequences with desirable binding properties |
| 02/24/2004 | US6696249 Using shigella as model system |
| 02/24/2004 | US6696247 Compounds and methods for therapy and diagnosis of lung cancer |
| 02/24/2004 | US6696246 Allowing stringent wash conditions reducing background signals without loss of hybrids |
| 02/24/2004 | US6696241 Measuring esterase activity |
| 02/24/2004 | US6696239 Comparative phenotype analysis for assessment of biological active compounds such as antimicrobials |
| 02/24/2004 | US6696062 BASB006 polypeptides from Neisseria meningitidis and immunogenic compositions thereof |
| 02/24/2004 | US6696022 Elongation structure comprising tapered channel formed on a chip; high throughput screening; nucleic acids, genomes |
| 02/24/2004 | US6695958 Electrochemical sensor |
| 02/24/2004 | US6695015 Ultralow expansion brake rubber hose and its production method |
| 02/24/2004 | CA2250014C Asymmetric benzoxanthene dyes |
| 02/24/2004 | CA2207555C Analytical kit |
| 02/24/2004 | CA2167822C Potentiometric biosensor and the method for its use |
| 02/24/2004 | CA2155182C Method of examining hormone-dependent tumor |
| 02/24/2004 | CA2132213C Specific detection of cell surface receptor leukocyte adhesion molecule-1 |
| 02/24/2004 | CA2119557C Selective restriction fragment amplification: a general method for dna fingerprinting |
| 02/22/2004 | CA2437979A1 Molecular constructs and methods of use for detection of biochemical reactions |
| 02/20/2004 | CA2437473A1 Method for preservation of cells and nucleic acid targets |
| 02/19/2004 | WO2004015421A1 Method and device for identifying micro organisms |
| 02/19/2004 | WO2004015420A1 Method for diagnosing multiple sclerosis |
| 02/19/2004 | WO2004015416A2 Methods for the identification of agents with anti-microbial action |
| 02/19/2004 | WO2004015413A1 The method and apparatus for determining the number of living cells in a test fluid |
| 02/19/2004 | WO2004015394A2 Cancer diagnostics and prognostics |
| 02/19/2004 | WO2004015391A2 Mass spectrometry-based identification of proteins |
| 02/19/2004 | WO2004015142A1 Uncoupling of dna propagation and expression of protein for phage display |
| 02/19/2004 | WO2004015141A2 Method for the rapid assessment of the presence and viability of bacterial cells and use thereof________________________ |
| 02/19/2004 | WO2004015140A1 Methods for the treatment of dementia based on apo e genotype |
| 02/19/2004 | WO2004015139A1 Method for amplification of nucleic acids of low complexity |
| 02/19/2004 | WO2004015138A1 Apparatus and methods for detecting dna in biological samples |
| 02/19/2004 | WO2004015137A1 Method for comparing gene expression level |
| 02/19/2004 | WO2004015136A1 Interpretation model for the uv-vis spectra of microorganisms |
| 02/19/2004 | WO2004015134A2 Method of determining the cleavage activity of an endonuclease |
| 02/19/2004 | WO2004015127A2 Anticodon-based libraries and molecules for the specific shotgun and/or direct targeting of, and/or interaction with cells, tissues, surfaces, materials, molecules, and energy fields |
| 02/19/2004 | WO2004015109A1 Human acid sensing ion channel 2b (hasic2b), process for producing the same, and its use |
| 02/19/2004 | WO2004015107A2 Further novel forms of interfering rna molecules |
| 02/19/2004 | WO2004015106A1 Methods to reprogram splice site selection in pre-messenger rnas |
| 02/19/2004 | WO2004015104A1 Method of diagnosing risk of restenosis after coronary angioplasty |
| 02/19/2004 | WO2004015100A1 Method of judging inflammatory disease |
| 02/19/2004 | WO2004015085A2 Method and compositions relating to 5’-chimeric ribonucleic acids |
| 02/19/2004 | WO2004015080A2 Nucleic acid detection methods using universal priming |
| 02/19/2004 | WO2004015076A2 Novel proteins and nucleic acids encoding same |
| 02/19/2004 | WO2004015073A2 MP21S AS MODIFIERS OF THE p21 PATHWAY AND METHODS OF USE |
| 02/19/2004 | WO2004015072A2 Mrbs as modifiers of the rb pathway and methods of use |
| 02/19/2004 | WO2004015071A2 CSNK1GS AS MODIFIERS OF THE p21 PATHWAY AND METHODS OF USE |
| 02/19/2004 | WO2004015070A2 Isolation and identification of t cells |
| 02/19/2004 | WO2004015063A2 Amplification and overexpression of oncogenes |
| 02/19/2004 | WO2004015062A2 Methods and compositions relating to gene silencing |
| 02/19/2004 | WO2004014433A1 Inhibition of proliferation and infiltration of brain tumor cells caused by expression of ampa-type glutamate receptor subunit |
| 02/19/2004 | WO2004014415A1 Growth hormone releasing peptides |
| 02/19/2004 | WO2004014414A1 Novel uses of rfrp and ot7t022 |
| 02/19/2004 | WO2004014319A2 Screening strategy for anticancer drugs |
| 02/19/2004 | WO2004014314A2 Methods and compositions concerning poxviruses and cancer |
| 02/19/2004 | WO2004014306A2 Compositions and methods for the treatment of diseases exhibiting protein misassembly and aggregation |
| 02/19/2004 | WO2004014301A2 PSMCs AS MODIFIERS OF THE RB PATHWAY AND METHODS OF USE |
| 02/19/2004 | WO2004014296A2 Method of detecting and preventing alzheimer’s disease, particularly at prodromal and early stages |
| 02/19/2004 | WO2004014222A2 Diagnosis and treatment of tuberous sclerosis |
| 02/19/2004 | WO2004014212A2 Self-assembled muscle-powered microdevices |
| 02/19/2004 | WO2004014128A1 Method of elevating ggt activity of plant, plant with elevated ggt activity and method of constructing the same |
| 02/19/2004 | WO2004007726A3 Brachyspira hyodysenteriae vaccine |
| 02/19/2004 | WO2004001016A3 Methods for detection of genetic alterations associated with cancer |
| 02/19/2004 | WO2003102584A3 Semaphorin-like proteins and methods of using same |
| 02/19/2004 | WO2003102137A3 Compositions and methods relating to lung specific genes and proteins |
| 02/19/2004 | WO2003100376A3 Hematological assay and kit |
| 02/19/2004 | WO2003097852A3 Assay for identifying inhibitors of fc gamma riii signaling |
| 02/19/2004 | WO2003097834A3 A method for in vitro molecular evolution of protein function |
| 02/19/2004 | WO2003097808A9 Automated system for isolating, amplyifying and detecting a target nucleic acid sequence |
| 02/19/2004 | WO2003095620A3 Oocyte recording chamber |
| 02/19/2004 | WO2003095605A3 A chimeric reverse transcriptase and methods for identifying telomerase inhibitors |
| 02/19/2004 | WO2003092581A9 Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions |
| 02/19/2004 | WO2003088979A3 Oligonucleotides from sequences coding for the surface component of envelope proteins of primate t-cell leukaemia/lymphoma viruses (ptlv) and uses thereof |
| 02/19/2004 | WO2003085124A8 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 02/19/2004 | WO2003080640B1 Lymphatic and blood endothelial cell genes |
| 02/19/2004 | WO2003078658A3 Methods for diagnosing and treating schizophrenia |
| 02/19/2004 | WO2003076892A3 Device and methods for measuring the response of at least one cell to a medium |
| 02/19/2004 | WO2003074734A3 Methods for detecting genome-wide sequence variations associated with a phenotype |
| 02/19/2004 | WO2003072803A3 Nanostructures containing antibody assembly units |
| 02/19/2004 | WO2003069347A3 Diagnostic and therapeutic use of caps |
| 02/19/2004 | WO2003068927A3 Method for influencing kinase activity with ag879 and ag879 derivatives |
| 02/19/2004 | WO2003065046A3 Diagnostics and therapeutics for diseases associated with a new human 5-ht6 receptor |
| 02/19/2004 | WO2003064605A3 Crude biological derivatives competent for nucleic acid detection |
| 02/19/2004 | WO2003062379A3 Molecules for disease detection and treatment |